# Boston Scientific Corporation (BSX) — Q1-2024 Earnings Results

**Report date:** 2024-04-24 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q1-2024

## Post-Earnings Brief

### Headline

Boston Scientific Misses on EPS, Stock Up 5.68%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.33 | N/A | -35.17% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their long-term strategy despite the EPS miss. They emphasized their commitment to growth and innovation.

**Key quotes:**

> Management highlighted ongoing investments in innovation and product development.

> They acknowledged the challenges faced in the current market environment.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Boston Scientific's Q1 2024 earnings report showed a significant EPS miss, which typically raises concerns among investors. However, the stock rose by 5.68%, likely driven by positive sentiment around their long-term strategy and ongoing investments in innovation. This reaction suggests that investors may be looking beyond the short-term earnings results.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q1-2024_